Thiomers for oral delivery of hydrophilic macromolecular drugs.
In recent years thiolated polymers (thiomers) have appeared as a promising new tool in oral drug delivery. Thiomers are obtained by the immobilisation of thio-bearing ligands to mucoadhesive polymeric excipients. By the formation of disulfide bonds with mucus glycoproteins, the mucoadhesive properties of thiomers are up to 130-fold improved compared with the corresponding unmodified polymers. Owing to the formation of inter- and intramolecular disulfide bonds within the thiomer itself, matrix tablets and particulate delivery systems show strong cohesive properties, resulting in comparatively higher stability, prolonged disintegration times and a more controlled drug release. The permeation of hydrophilic macromolecular drugs through the gastrointestinal (GI) mucosa can be improved by the use of thiomers. Furthermore, some thiomers exhibit improved inhibitory properties towards GI peptidases. The efficacy of thiomers in oral drug delivery has been demonstrated by various in vivo studies. A pharmacological efficacy of 1%, for example, was achieved in rats by oral administration of calcitonin tablets comprising a thiomer. Furthermore, tablets comprising a thiomer and pegylated insulin resulted in a pharmacological efficacy of 7% after oral application to diabetic mice. Low-molecular-weight heparin embedded in thiolated polycarbophil led to an absolute bioavailability of > or = 20% after oral administration to rats. In these studies, formulations comprising the corresponding unmodified polymer had only a marginal or no effect. These results indicate drug carrier systems based on thiomers appear to be a promising tool for oral delivery of hydrophilic macromolecular drugs.
Bernkop-Schnürch
Andreas
A
Leopold-Franzens-University Innsbruck, Department of Pharmaceutical Technology, Institute of Pharmacy, Innrain 52, Josef Moller Haus, A-6020 Innsbruck, Austria. andreas.bernkop@uibk.ac.at
Hoffer
Martin H
MH
Kafedjiiski
Krum
K
D000284:Administration, Oral; D000818:Animals; D004337:Drug Carriers / Q000737:chemistry*; D006801:Humans; D046911:Macromolecular Substances / Q000008:administration & dosage* / Q000737:chemistry; D015394:Molecular Structure; D004364:Pharmaceutical Preparations / Q000008:administration & dosage* / Q000737:chemistry; D011108:Polymers / Q000737:chemistry; D012995:Solubility; D013438:Sulfhydryl Compounds / Q000737:chemistry*
D004337:Drug Carriers; D046911:Macromolecular Substances; D004364:Pharmaceutical Preparations; D011108:Polymers; D013438:Sulfhydryl Compounds